SCHEMBL5124217

SCHEMBL5124217

COc1cccc(-c2ccc3c(c2)CCC/C3=N\O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.46
MAPT P10636 2/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TMEM97 Q5BJF2 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
ALOX12 P18054 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
BRAF P15056 1/20 0.42
ADORA1 P30542 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
FGFR1 P11362 1/20 0.41
HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5124219 1.00 ESR1 (0.46) ESR1MAPTMAPK1ALDH1A1KMT2A
SCHEMBL1809661 0.84 MAPT (0.55) ESR1MAPTMAPK1ALDH1A1KMT2A
SCHEMBL11971460 0.84 MAPT (0.55) ESR1MAPTMAPK1ALDH1A1KMT2A
SCHEMBL1806126 0.84 MAPT (0.55) ESR1MAPTMAPK1ALDH1A1KMT2A
SCHEMBL5123714 0.82 PARP10 (0.50) MAPTMAPK1ALDH1A1TDP1HPGD
SCHEMBL5123710 0.82 PARP10 (0.50) MAPTMAPK1ALDH1A1TDP1HPGD
SCHEMBL9488600 0.82 HPGD (0.57) ESR1MAPK1HPGDL3MBTL1LMNA
SCHEMBL4085727 0.80 HSD17B1 (0.60) ESR1TMEM97SIGMAR1FGFR1DHODH
SCHEMBL5116961 0.80 PARP10 (0.50) MAPTMAPK1ALDH1A1KMT2AHPGD
SCHEMBL5116955 0.80 PARP10 (0.50) MAPTMAPK1ALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR ESR1 30/4885MAPT 4749/4885MAPK1 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.